KeyGene webinar: R&D as a success factor for the biologicals industry

October 12, 2021

Together with some of its partners, KeyGene will share successes of- and views on R&D as a success factor for the biologicals industry, by organizing a webinar

R&D as a success factor for the biologicals industry

Tuesday October 12, 2021, 15:30-17:00 CET.

The webinar will give the floor to industry representatives, showing some of the industry’s successes achieved through R&D. During the webinar, KeyGene will present its vision on optimal R&D support for the biologicals industry.

You can now register for the webinar, free of cost.

Our speakers:

  • Martijn Olde Weghuis, Business Development Manager Valorization, Vitens
  • Andre Negreiros, EMEA Regional Seed Applied Technologies Leader, Corteva
  • Irene de Bruijn , Researcher at Koppert Biological Systems
  • Arjen van Tunen, CEO KeyGene
  • Frank Hoeberichts, Biologicals Research Expert, KeyGene

Contribute to sustainability

The biologicals industry has the ambition to play a leading role in transforming the traditional agriculture paradigm, and thus becoming the driver for a more sustainable food production worldwide. For that, the industry wants and needs to innovate at an unprecedented pace. Research & development can be a silver bullet, for the short-term and long-term successes of individual companies and the success of the industry in realizing this ambition.

Starting from very early product definition, research and development can support product developers to make choices by using e.g. genetic analysis and computer modeling, prior to actually making and testing a new product or formulation. Accurate selection of the potentially most interesting formulations is essential to minimize downstream efforts and costs, while at the same time increase the chances of success.

Impact proved and understood  

Because crops are developing and growing in a complex ecosystem, a thorough understanding of how and why a biologicals product is effective is crucial. to maximally use the potential of a biological. A multidisciplinary approach, bringing together different types of specialists, can clarify the dynamics that are taking place. For example, by combining different omics technologies, such as genomics and metabolomics, and advanced digital phenotyping, R&D can reveal which biological processes are triggered by treatment with biologicals. An R&D approach like that can show how products affect the crop itself as well as microorganisms in the rhizosphere – using metagenomics or metatranscriptomics – , or show how a product interacts with a target pest or disease.

Increased knowledge and understanding of existing products can pave the way to optimally design next generations of biologicals. New insights can also be used for the development of technologies that will improve the efficacy of the application of biologicals.


R&D to support business

It is thus clear that R&D programs can have a positive impact all across a biologicals company. R&D results will support product developers in selecting the best products and determining their best positioning in the market. Through  R&D, product managers, regulatory affairs, and marketing and sales teams can be supplied with convincing evidence about the efficacy and the mode of action of products. Potential customers and regulators can then be shown how effective the product is and why. The positive impact of R&D on individual biologicals companies will of course also support the industry as a whole in making agriculture more sustainable.

Learn more about how R&D can have a positive impact on your own business now, and/or register for KeyGene’s webinar “R&D as a success factor for the biologicals industry”



More Events